Mintz Levin To Serve as Premier Sponsor for "The Commercial Implications of Personalized Medicine" for the Tech Council of Maryland's BioBreakfast Series
2/26/2010
On Friday, February 26, 2010, Mintz Levin will serve as a premier sponsor for "The Commercial Implications of Personalized Medicine" for the Tech Council of Maryland's BioBreakfast Series. Karen S. Lovitch, a member in the Health Law practice, will be moderating the panel, which will discuss such topics as commercial breakthroughs, as well as the regulatory and legislative developments expected to affect the advancement of personalized medicine in the near-term.
For more information on this event, click here.
